China Biologic Products buy tamam
Start price
22.03.17
/
50%
€88.87
Target price
04.11.21
€123.21
Performance (%)
11.97%
End price
05.11.21
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 11.97%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| China Biologic Products | - | - | - | - |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% | 57.846% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% | 84.823% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% | 54.805% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% | 64.029% |
Comments by tamam for this prediction
In the thread China Biologic Products diskutieren
CBPO's financials are solid; growth is healthy
tamam stimmt am 22.03.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 136.6$ zu.
This stock offers remarkably low risk, but the upside will depend largely on the whims of the market.
At 10 price/sales, CBPO may seem expensive to most U.S investors, but quality comes at a premium. Even at these multiples, the stock represents a better value than many U.S firms in this tense political
climate.
In the thread Trading China Biologic Products
Die von tamam gewählte maximale Laufzeit wurde überschritten